Molecular Partners Ag (MOLN) Non-Current Assets (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Non-Current Assets of $6040.2 for Q1 2026, up 31.05% year-on-year from $4609.2 in Q1 2025, and down 7.71% on a QoQ basis from $6544.9 in Q4 2025.

Molecular Partners Ag (MOLN) Non-Current Assets (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Non-Current Assets for 7 consecutive years, with $6040.2 the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Assets rose 31.05% year-over-year to $6040.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6040.2 (up 31.05% YoY) and the FY2025 annual result came in at $6544.9, up 35.0% from the prior year.
  • Non-Current Assets declined to $6040.2 in Q1 2026 per MOLN's latest filing, from $6544.9 in the prior quarter.
  • Over the last five years, Non-Current Assets for MOLN reached as high as $8.1 million in Q2 2022 and fell as low as $3987.8 in Q3 2025.
  • A 5-year average of $1.2 million and a median of $6643.5 in 2023 frame the typical range for Non-Current Assets.
  • The largest YoY upside for Non-Current Assets was 35.0% in 2025 against a maximum downside of 99.92% in 2025.
  • Year by year, Non-Current Assets stood at $7791.4 in 2022, then declined by 14.73% to $6643.5 in 2023, then retreated by 27.03% to $4848.0 in 2024, then soared by 35.0% to $6544.9 in 2025, then decreased by 7.71% to $6040.2 in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $6040.2, $6544.9, and $3987.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - 6,040.23

Historic Data

Download Data
DateValue
Mar 31, 2026 6,040.23
Dec 31, 2025 6,544.87
Sep 30, 2025 3,987.85
Jun 30, 2025 4,452.28
Mar 31, 2025 4,609.17
Dec 31, 2024 4,848.04
Sep 30, 2024 5,401.69
Jun 30, 2024 5.54 Mn
Mar 31, 2024 6,208.45
Dec 31, 2023 6,643.50
Sep 30, 2023 7,002.36
Jun 30, 2023 7.38 Mn
Mar 31, 2023 7,627.60
Dec 31, 2022 7,791.39
Sep 30, 2022 7,741.07
Jun 30, 2022 8.11 Mn
Mar 31, 2022 8,915.84
Dec 31, 2021 9,193.32
Sep 30, 2021 9,489.58
Dec 31, 2020 10,767.32